Clostridia as live biotherapeutics: can modified <i>Clostridium</i> species enhance disease treatments?-Reference-Cited by-同舟云学术

Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?

Published:2023-05 Issue:7 Volume:18 Page:385-388
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

Kubiak Alekandra M¹²^ORCID,de Laak Jella van¹,Zhang Yanchao¹,Bailey Tom S¹,Claessen Luuk¹,Hittmeyer Philip¹,Vlaswinkel Carlijn¹,Mowday Alexsandra³^ORCID,Dubois Ludwig J¹^ORCID,Theys Jan¹^ORCID

Affiliation:

1. Department of Precision Medicine, The M-Lab, GROW – School of Oncology, Maastricht University, Maastricht, 6200, MD, The Netherlands

2. Exomnis Biotech BV, Maastricht, 6229, EV, The Netherlands

3. Auckland Cancer Society Research Centre, University of Auckland, Auckland, 1023, New Zealand

Funder

Dutch Cancer society KWF

Publisher

Future Medicine Ltd

Subject

Microbiology (medical),Microbiology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fmb-2022-0220

Reference20 articles.

1. Probiotics: current landscape and future horizons

2. Bugging Tumors: Figure 1.

3. Clostridium species as probiotics: potentials and challenges

4. Efficient Secretion of Murine IL-2 From an Attenuated Strain of Clostridium sporogenes, a Novel Delivery Vehicle for Cancer Immunotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination;Microbial Cell Factories;2024-04-24

2. Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia;Microbiology Spectrum;2023-12-12